EXPERTS COUNCIL RESOLUTION/ CLINICAL SIGNS, MANAGEMENT AND MONITORING ALGORITHMS OF PATIENTS WITH MPS I WHO HAVE UNDERGONE HEMATOPOIETIC STEM CELL TRANSPLANTATION. THE ROLE OF ERT IN MPS I MANAGEMENT AFTER HSCT
.
Main Author: | article Editorial |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2021-05-01
|
Series: | Voprosy Sovremennoj Pediatrii |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/2597 |
Similar Items
-
Differences in MPS I and MPS II Disease Manifestations
by: Christiane S. Hampe, et al.
Published: (2021-07-01) -
MPS i molnet
by: Johansson, Björn, et al.
Published: (2014) -
A Labour MP’s Experience
by: Peter Kilfoyle
Published: (2003-04-01) -
Obstructive Sleep Apnea in MPS
by: Abhijit Ricky Pal MBBChir, MA, MD, FRCS(ORL-HNS), et al.
Published: (2015-11-01) -
Mucopolysaccharidosis type I (MPS I). Multidiciplinary aspects and clinical guidelines
by: Imelda Martínez Núñez, et al.
Published: (2017-06-01)